454 related articles for article (PubMed ID: 26188116)
1. Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop.
Ramirez T; Beken S; Chlebus M; Ellis G; Griesinger C; De Jonghe S; Manou I; Mehling A; Reisinger K; Rossi LH; van Benthem J; van der Laan JW; Weissenhorn R; Sauer UG
Regul Toxicol Pharmacol; 2015 Oct; 73(1):210-26. PubMed ID: 26188116
[TBL] [Abstract][Full Text] [Related]
2. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
Beken S; Kasper P; van der Laan JW
Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
[TBL] [Abstract][Full Text] [Related]
3. Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).
Kinsner-Ovaskainen A; Maxwell G; Kreysa J; Barroso J; Adriaens E; Alépée N; Berg N; Bremer S; Coecke S; Comenges JZ; Corvi R; Casati S; Dal Negro G; Marrec-Fairley M; Griesinger C; Halder M; Heisler E; Hirmann D; Kleensang A; Kopp-Schneider A; Lapenna S; Munn S; Prieto P; Schechtman L; Schultz T; Vidal JM; Worth A; Zuang V
Altern Lab Anim; 2012 Jul; 40(3):175-81. PubMed ID: 22943518
[TBL] [Abstract][Full Text] [Related]
4. Overcoming barriers to validation of non-animal partial replacement methods/Integrated Testing Strategies: the report of an EPAA-ECVAM workshop.
Kinsner-Ovaskainen A; Akkan Z; Casati S; Coecke S; Corvi R; Dal Negro G; De Bruijn J; De Silva O; Gribaldo L; Griesinger C; Jaworska J; Kreysa J; Maxwell G; McNamee P; Price A; Prieto P; Schubert R; Tosti L; Worth A; Zuang V
Altern Lab Anim; 2009 Sep; 37(4):437-44. PubMed ID: 19807215
[TBL] [Abstract][Full Text] [Related]
5. International Harmonization and Cooperation in the Validation of Alternative Methods.
Barroso J; Ahn IY; Caldeira C; Carmichael PL; Casey W; Coecke S; Curren R; Desprez B; Eskes C; Griesinger C; Guo J; Hill E; Roi AJ; Kojima H; Li J; Lim CH; Moura W; Nishikawa A; Park H; Peng S; Presgrave O; Singer T; Sohn SJ; Westmoreland C; Whelan M; Yang X; Yang Y; Zuang V
Adv Exp Med Biol; 2016; 856():343-386. PubMed ID: 27671730
[TBL] [Abstract][Full Text] [Related]
6. Finding synergies for the 3Rs - Repeated Dose Toxicity testing: Report from an EPAA Partners' Forum.
Laroche C; Annys E; Bender H; Botelho D; Botham P; Brendler-Schwaab S; Clayton R; Corvaro M; Dal Negro G; Delannois F; Dent M; Desaintes C; Desprez B; Dhalluin S; Hartmann A; Hoffmann-Doerr S; Hubesch B; Irizar A; Manou I; Müller BP; Nadzialek S; Prieto P; Rasenberg M; Roggeband R; Rowan TG; Schutte K; van de Water B; Westmoreland C; Whelan M; Wilschut A; Zvonimir Z; Cronin MTD
Regul Toxicol Pharmacol; 2019 Nov; 108():104470. PubMed ID: 31479718
[TBL] [Abstract][Full Text] [Related]
7. The European Partnership for Alternative Approaches to Animal Testing (EPAA): promoting alternative methods in Europe and beyond.
Cozigou G; Crozier J; Hendriksen C; Manou I; Ramirez-Hernandez T; Weissenhorn R
J Am Assoc Lab Anim Sci; 2015 Mar; 54(2):209-13. PubMed ID: 25836968
[TBL] [Abstract][Full Text] [Related]
8. Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods.
Schechtman LM
ILAR J; 2002; 43 Suppl():S85-94. PubMed ID: 12388858
[TBL] [Abstract][Full Text] [Related]
9. Modern science for better quality control of medicinal products "Towards global harmonization of 3Rs in biologicals": The report of an EPAA workshop.
Schutte K; Szczepanska A; Halder M; Cussler K; Sauer UG; Stirling C; Uhlrich S; Wilk-Zasadna I; John D; Bopst M; Garbe J; Glansbeek HL; Levis R; Serreyn PJ; Smith D; Stickings P
Biologicals; 2017 Jul; 48():55-65. PubMed ID: 28596049
[TBL] [Abstract][Full Text] [Related]
10. Use of New Approach Methodologies (NAMs) in regulatory decisions for chemical safety: Report from an EPAA Deep Dive Workshop.
Westmoreland C; Bender HJ; Doe JE; Jacobs MN; Kass GEN; Madia F; Mahony C; Manou I; Maxwell G; Prieto P; Roggeband R; Sobanski T; Schütte K; Worth AP; Zvonar Z; Cronin MTD
Regul Toxicol Pharmacol; 2022 Nov; 135():105261. PubMed ID: 36103951
[TBL] [Abstract][Full Text] [Related]
11. The Third FRAME Toxicity Committee: working toward greater implementation of alternatives in toxicity testing.
Combes RD; Balls M; Bansil L; Barratt M; Bell D; Botham P; Broadhead C; Clothier R; George E; Fentem J; Jackson M; Indans I; Loizou G; Navaratnam V; Pentreath V; Phillips B; Stemplewski H; Stewart J
Altern Lab Anim; 2004 Jun; 32 Suppl 1B():635-42. PubMed ID: 23581152
[TBL] [Abstract][Full Text] [Related]
12. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM).
Stokes WS; Schechtman LM; Hill RN
Altern Lab Anim; 2002 Dec; 30 Suppl 2():23-32. PubMed ID: 12513648
[TBL] [Abstract][Full Text] [Related]
13. A new path forward: the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and National Toxicology Program's Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM).
Casey W; Jacobs A; Maull E; Matheson J; Clarke C; Lowit A
J Am Assoc Lab Anim Sci; 2015 Mar; 54(2):170-3. PubMed ID: 25836963
[TBL] [Abstract][Full Text] [Related]
14. Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testing.
Hamm J; Sullivan K; Clippinger AJ; Strickland J; Bell S; Bhhatarai B; Blaauboer B; Casey W; Dorman D; Forsby A; Garcia-Reyero N; Gehen S; Graepel R; Hotchkiss J; Lowit A; Matheson J; Reaves E; Scarano L; Sprankle C; Tunkel J; Wilson D; Xia M; Zhu H; Allen D
Toxicol In Vitro; 2017 Jun; 41():245-259. PubMed ID: 28069485
[TBL] [Abstract][Full Text] [Related]
15. Workshop on acceleration of the validation and regulatory acceptance of alternative methods and implementation of testing strategies.
Piersma AH; Burgdorf T; Louekari K; Desprez B; Taalman R; Landsiedel R; Barroso J; Rogiers V; Eskes C; Oelgeschläger M; Whelan M; Braeuning A; Vinggaard AM; Kienhuis A; van Benthem J; Ezendam J
Toxicol In Vitro; 2018 Aug; 50():62-74. PubMed ID: 29501630
[TBL] [Abstract][Full Text] [Related]
16. Currently available in vitro methods used in the regulatory toxicology.
Liebsch M; Spielmann H
Toxicol Lett; 2002 Feb; 127(1-3):127-34. PubMed ID: 12052650
[TBL] [Abstract][Full Text] [Related]
17. The vaccines consistency approach project: an EPAA initiative.
De Mattia F; Hendriksen C; Buchheit KH; Chapsal JM; Halder M; Lambrigts D; Redhead K; Rommel E; Scharton-Kersten T; Sesardic T; Viviani L; Ragan I
Pharmeur Bio Sci Notes; 2015; 2015():30-56. PubMed ID: 26830158
[TBL] [Abstract][Full Text] [Related]
18. Alternatives for skin sensitisation: Hazard identification and potency categorisation: Report from an EPAA/CEFIC LRI/Cosmetics Europe cross sector workshop, ECHA Helsinki, April 23rd and 24th 2015.
Basketter D; Ashikaga T; Casati S; Hubesch B; Jaworska J; de Knecht J; Landsiedel R; Manou I; Mehling A; Petersohn D; Rorije E; Rossi LH; Steiling W; Teissier S; Worth A
Regul Toxicol Pharmacol; 2015 Nov; 73(2):660-6. PubMed ID: 26456663
[TBL] [Abstract][Full Text] [Related]
19. Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods.
Casati S; Aschberger K; Barroso J; Casey W; Delgado I; Kim TS; Kleinstreuer N; Kojima H; Lee JK; Lowit A; Park HK; Régimbald-Krnel MJ; Strickland J; Whelan M; Yang Y; Zuang V
Arch Toxicol; 2018 Feb; 92(2):611-617. PubMed ID: 29127450
[TBL] [Abstract][Full Text] [Related]
20. Report of the Validation and Technology Transfer Committee of the Johns Hopkins Center for Alternatives to Animal Testing. Framework for validation and implementation of in vitro toxicity tests.
Goldberg AM; Frazier JM; Brusick D; Dickens MS; Flint O; Gettings SD; Hill RN; Lipnick RL; Renskers KJ; Bradlaw JA
Xenobiotica; 1993 May; 23(5):563-72. PubMed ID: 8342302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
